Related Experiment Video
Updated: Jun 29, 2025

10:13
Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
7.5K
Mitochondrial Calcium Uniporter (MCU) is Involved in an Ischemic Postconditioning Effect Against Ischemic Reperfusion
Hiromitsu Sasaki1, Ichiro Nakagawa2, Takanori Furuta1
1Department of Neurosurgery, Nara Medical University, Shijo-Cho 840, Kashihara City, Nara, 634-8522, Japan.
Cellular and Molecular Neurobiology
|April 3, 2024
Summary
Mitochondrial calcium uniporter (MCU) plays a key role in neuroprotection during ischemic reperfusion injury. Inhibiting MCU disrupts protective mechanisms, increasing neuronal damage and calcium overload.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Ischemic Injury
Background:
- Ischemic postconditioning (PostC) offers neuroprotection against ischemic reperfusion (I/R) injury.
- Mitochondrial calcium uniporter (MCU) regulates calcium (Ca2+) uptake and is a potential therapeutic target for neurological diseases.
Purpose of the Study:
- To investigate the role of MCU in the neuroprotective mechanisms of PostC.
- To determine if MCU inhibition affects cellular responses during PostC.
Main Methods:
- Whole-cell patch-clamp electrophysiology on hippocampal CA1 pyramidal cells in C57BL mice.
- Measurement of spontaneous excitatory post-synaptic currents (sEPSCs), intracellular Ca2+ concentration, mitochondrial membrane potential, and N-methyl-D-aspartate receptor (NMDAR) currents.
- Inhibition of MCU using ruthenium red 265 (Ru265) during PostC.
Main Results:
- Inhibition of MCU significantly increased sEPSCs, NMDAR currents, intracellular Ca2+ concentration, and cell death post-reperfusion.
- Mitochondrial depolarization during PostC was attenuated when MCU was inhibited.
- These changes indicate a removal of PostC's neuroprotective effects.
Conclusions:
- MCU is involved in mitochondrial depolarization during PostC.
- MCU activity is crucial for suppressing NMDAR over-activation and preventing excessive intracellular Ca2+ elevation.
- Targeting MCU may offer a novel therapeutic strategy for mitigating I/R injury.

